Drugs / Barrier Renew
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05961579 | Aug → Nov 2023 | rosacea | Goldman, Butterwick, Fitzpatrick and Groff | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Barrier Renew | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05961579 ↗ |